OpenURL Connection Search

Select item for more details and to access through your institution.

OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes.
Published in:
Brain: A Journal of Neurology, 2008, v. 131, n. 2, p. 338, doi. 10.1093/brain/awm298
By:
- Patrizia Amati-Bonneau;
- Maria Lucia Valentino;
- Pascal Reynier;
- Maria Esther Gallardo;
- Belén Bornstein;
- Anne Boissière;
- Yolanda Campos;
- Henry Rivera;
- Jesús González de la Aleja;
- Rosanna Carroccia;
- Luisa Iommarini;
- Pierre Labauge;
- Dominique Figarella-Branger;
- Pascale Marcorelles;
- Alain Furby;
- Katell Beauvais;
- Franck Letournel;
- Rocco Liguori;
- Chiara La Morgia;
- Pasquale Montagna
Publication type:
Article
A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16.
Published in:
Human Molecular Genetics, 2011, v. 20, n. 10, p. 1893, doi. 10.1093/hmg/ddr071
By:
- Carelli, Valerio;
- Schimpf, Simone;
- Fuhrmann, Nico;
- Valentino, Maria Lucia;
- Zanna, Claudia;
- Iommarini, Luisa;
- Papke, Monika;
- Schaich, Simone;
- Tippmann, Sabine;
- Baumann, Britta;
- Barboni, Piero;
- Longanesi, Lora;
- Rugolo, Michela;
- Ghelli, Anna;
- Alavi, Marcel V.;
- Youle, Richard J.;
- Bucchi, Laura;
- Carroccia, Rosanna;
- Giannoccaro, Maria Pia;
- Tonon, Caterina
Publication type:
Article
Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.
Published in:
British Journal of Haematology, 2003, v. 120, n. 6, p. 953, doi. 10.1046/j.1365-2141.2003.04176.x
By:
- Rigolin, Gian Matteo;
- Tieghi, Alessia;
- Ciccone, Maria;
- Bragotti, Letizia Zenone;
- Cavazzini, Francesco;
- Porta, Matteo Della;
- Castagnari, Barbara;
- Carroccia, Rosanna;
- Guerra, Giovanni;
- Cuneo, Antonio;
- Castoldi, Gianluigi
Publication type:
Article

Found: 3

OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes.

A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16.

Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.